MentionFox
Home › funding signals › GENHEALTH, INC.
Form D · on the record

GENHEALTH — $16.50M Form D filing, September 2026

GENHEALTH, INC. filed a Form D with the Securities and Exchange Commission on 2026-09-29.

GENHEALTH, INC. filed a Form D notice of an exempt securities offering with the SEC on September 29, 2026. The filing reports $16.50M sold. Its industry group is Biotechnology. It names Ritwik Sahu (Executive Officer, Director), Ethan Siegel (Director), Kahini Shah (Director) (SEC Form D, September 29, 2026).

5 more Biotechnology raises within 90 days of this one ↓

Sell to companies like GENHEALTH, INC? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Key facts

Run the free check on GENHEALTH, INC. →

GENHEALTH, INC.

New Form D on file · 2026-09-29 · the record

$16.50M
raise on the record
D
filing
8
investors in
VIRGINIA
based
Open the record →

What the record says

FilingForm D
Filed2026-09-29
Industry groupBiotechnology
Entity typeCorporation
Incorporated inDELAWARE
Year formed2023
BasedVIENNA, VIRGINIA
CIK1980883
Accession0001980883-26-000003

Pitching, partnering or investing alongside them? See who really runs and owns GENHEALTH, INC.

Watch GENHEALTH, INC.

Free to see. No signup.

Keep reading

More on the people and the money behind GENHEALTH, INC., from the filings we hold.

More raises like this

Biotechnology raises filed within 90 days of this one, largest first.

What do you want to do with GENHEALTH, INC.?

Get the full cited report on GENHEALTH, INC.

What the filing shows about GENHEALTH, INC.

  • 8 investors had already put money in when it filed.
  • The filing names 4 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on GENHEALTH, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

What the filing says

  • Offered: $16,499,983. Sold: $16,499,983. Left to sell: nothing, all of it is sold. (filing)
  • Investors: 8 had already invested. (filing)
  • Date of first sale: August 4, 2026. (filing)
  • Types of securities: Equity. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on GENHEALTH, INC. See pricing

Filing history · 2 filings on this registrant
Form D · 2023-06-09 · $13MForm D · 2026-09-29 · $16.50M · this page 2023-06-09 2026-09-29

Each marker is one filing. The larger marker is the filing this page is about.

Biotechnology · by week
This raise, $16.50M, filed week of Sep 28

Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $16.50M, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on GENHEALTH, INC.?

What the filing shows about GENHEALTH, INC.

  • 8 investors had already put money in when it filed.
  • The filing names 4 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on GENHEALTH, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on GENHEALTH, INC. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind GENHEALTH, INC.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for GENHEALTH, INC.. With no account yet, you sign up free and land on the result.

Share this page

Just raised? Share it.

GENHEALTH, INC.: Raised $16.50M, Form D filed 2026-09-29

Cite this page

Permanent URL: https://mentionfox.com/funding/genhealth-inc-form-d-000003
Last updated 2026-10-20
Primary record: SEC filing 1 · SEC filing 2
GENHEALTH raised $16.50M — SEC Form D filing, September 2026. MentionFox, 2026-10-20. https://mentionfox.com/funding/genhealth-inc-form-d-000003